Cargando…
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
In 2011, intranasally administered live attenuated influenza vaccine (LAIV) was approved in the EU for prophylaxis of seasonal influenza in 2–17-year-old children. Our objective was to estimate the potential epidemiological impact and cost-effectiveness of an LAIV-based extension of the influenza va...
Autores principales: | Damm, Oliver, Eichner, Martin, Rose, Markus Andreas, Knuf, Markus, Wutzler, Peter, Liese, Johannes Günter, Krüger, Hagen, Greiner, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435640/ https://www.ncbi.nlm.nih.gov/pubmed/24859492 http://dx.doi.org/10.1007/s10198-014-0586-4 |
Ejemplares similares
-
The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
por: Rose, Markus A, et al.
Publicado: (2014) -
4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany
por: Eichner, Martin, et al.
Publicado: (2014) -
Epidemiology and cost of seasonal influenza in Germany - a claims data analysis
por: Scholz, Stefan, et al.
Publicado: (2019) -
Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations
por: Schmidt-Ott, Ruprecht, et al.
Publicado: (2019) -
Cost-effectiveness of human papillomavirus vaccination in Germany
por: Damm, Oliver, et al.
Publicado: (2017)